{'text': 'Blinatumomab Achieves Complete Molecular Responses in Majority of B-Cell Leukemia Patients', 'publisher': {'href': 'https://ascopost.com', 'title': 'The ASCO Post'}, 'created_at': 'Sun, 25 Jan 2015 08:00:00 GMT', 'description': 'Blinatumomab Achieves Complete Molecular Responses in Majority of B-Cell Leukemia Patients  The ASCO Post', 'url': 'https://news.google.com/rss/articles/CBMi0AFBVV95cUxPUUhDOWZiemNYVVBPNmVybVR3ZUp5a28tZ2h5cXVQNzhtZFJoeGxGZk00QlJzNDAyeVozTF83VG03STNUMFg4MjdObGo4a0lsWVJRUkRMNnJnendsUVc2Y1FqWU1KeEUwdVZ6YjNGVmxnVTdJR3ZvSkRYcEczckI5OXJ3RkFJeEFabEREb2stSDNtT0VfcGFFTzF6STlDZ24yLWduem5kSzNDMlhacmZ6QTNSOTNBeFFCMXZmNUM1YV9aZHAxR044QkJ1RlRGMVVf?oc=5&hl=en-US&gl=US&ceid=US:en'}
